<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940912-0-00063</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (1) AET has a high potential for abuse; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) AET has no currently accepted medical use in treatment in the United States; and, <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) There is a lack of accepted safety for use of AET under medical supervision. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=10 g=1 f=1 --> These findings are consistent with the placement of AET into Schedule I of the CSA. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All regulations applicable to Schedule I substances continue to be in effect as of September 12, 1994 with respect to AET. This substance has been in Schedule I pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h) since March 12, 1993. The current applicable regulations are as follows: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 1.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Registration.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Any person who manufactures, distributes, delivers, imports or exports AET or who engages in research or conducts instructional activities with respect to AET, or who proposes to engage in such activities, must be registered to conduct such activity in accordance with parts 1301 and 1311 of Title 21 of the Code of Federal Regulations. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Security.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Alpha-ethyltryptamine must be manufactured, distributed and stored in accordance with &sect;&sect;1301.71&hyph;1301.76 of Title 21 of the Code of Federal Regulations. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Labeling and Packaging.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All labels and labeling for commercial containers of AET must comply with &sect;&sect;1302.03&hyph;1302.05, 1302.07 and 1302.08 of Title 21 of the Code of Federal Regulations. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 4.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Quotas.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All persons required to obtain quotas for AET shall submit applications pursuant to &sect;&sect;1303.12 and 1303.22 of Title 21 of the Code of Federal Regulations. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 5.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Inventory.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Every registrant required to keep records and who possesses any quantity of AET shall take an inventory of all stocks of AET on hand pursuant to &sect;&sect;1304.11&hyph;1304.19 of Title 21 of the Code of Federal Regulations. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 6.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Records.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All registrants required to keep records pursuant to &sect;&sect;1304.21&hyph;1304.27 of Title 21 of the Code of Federal Regulations shall maintain such records on AET. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 7.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Reports.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All registrants required to submit reports pursuant to &sect;&sect;1304.34&hyph;1304.37 of Title 21 of the Code of Federal Regulations shall do so regarding AET. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 8.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Order Forms.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All registrants involved in the distribution of AET must comply with &sect;&sect;1305.01&hyph;1305.16 of Title 21 of the Code of Federal Regulations. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 9.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Importation and Exportation.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All importation and exportation of AET shall be in compliance with part 1312 of Title 21 of the Code of Federal Regulations. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 10.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Criminal Liability.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Any activity with respect to AET not authorized by, or in violation of, the CSA or the Controlled Substances Import and Export Act shall be unlawful. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The Deputy Administrator of the DEA hereby certifies that the placement of AET into Schedule I of the CSA will have no significant impact upon entities whose interests must be considered under the Regulatory Flexibility Act, 5 U.S.C. 601  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> et seq.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> This action involves the control of a substance with no currently accepted medical use in the United States. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> In accordance with the provisions of 21 U.S.C. 811(a), this scheduling action is a formal rulemaking. Such proceedings are conducted pursuant to the provisions of 5 U.S.C. 556 and 557 and, as such, are exempt from review by the Office of Management and Budget pursuant to Executive Order 12866, 3(d)(1). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> This action has been analyzed in accordance with the principles and criteria in Executive Order 12612, and it has been determined that this final rule does not have sufficient federalism implications to warrant the preparation of a Federalism Assessment. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> List of Subjects in 21 CFR Part 1308 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Administrative practice and procedure, Drug traffic control, Narcotics, Prescription drugs. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Under the authority vested in the Attorney General by Section 201(a) of the CSA (21 U.S.C. 811(a)), and delegated to the Administrator of the DEA by the Department of Justice regulations (28 CFR 0.100) and redelegated by the Administrator to the Deputy Administrator pursuant to 28 CFR 0.104 (59 FR 23637 (May 6, 1994)), the Deputy Administrator hereby orders that 21 CFR Part 1308 be amended as follows: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> PART 1308_[AMENDED] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. The authority citation for 21 CFR part 1308 continues to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Authority:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 21 U.S.C. 811, 812, 871b, unless otherwise noted. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. Section 1308.11 is amended by redesignating paragraphs (d)(1) through (d)(29) as (d)(2) through (d)(30) and by adding paragraph (d)(1) to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;1308.11 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Schedule I. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (d) *&blank;*&blank;* <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=38 g=1 f=1 --> (1) Alpha-ethyltryptamine  <!-- PJG 0114 ellipses --> 7249 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Some trade or other names: etryptamine; Monase;  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=6 f=1 --> a <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole;  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=6 f=1 --> a <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -ET; and AET. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;1308.11 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> [Amended] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 3. Section 1308.11 is further amended by removing paragraph (g)(3) and redesignating paragraph (g)(4) as (g)(3). <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: September 2, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Stephen H. Greene, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Deputy Administrator. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;22417 Filed 9&hyph;9&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4410&hyph;09&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            